Samsung Bioepis’ Trastuzumab Prequalified By WHO

Ontruzant Is First Ever Biosimilar Prequalified By Organization

 
• By Dave Wallace

Samsung Bioepis’ Ontruzant trastuzumab biosimilar has become the first biosimilar to be prequalified by the World Health Organization.

WHO
WHO Prequalifies Samsung Bioepis’ Trastuzumab • Source: Shutterstock

More from Biosimilars

More from Products